KN
Keay Nakae Chardan Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
78
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
80%
Neutral
20%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Health Information Services
Medical Care Facilities
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $14 |
227%
upside
| 2 | -4.3% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Buy
Maintained
| $80 |
25%
upside
| 3 | +31% |
0
%
| 7 Jan ‘26 11 days ago |
|
|
|
Buy
Maintained
| $2 |
456%
upside
| 1 | +16% |
0
%
| 5 Jan ‘26 13 days ago |
|
|
|
Buy
Maintained
| $35 |
22%
upside
| 1 | -7.1% |
0
%
| 5 Jan ‘26 13 days ago |
|
|
|
Buy
Maintained
| $30 |
75%
upside
| 1 | +3.5% |
0
%
| 5 Jan ‘26 13 days ago |
|
|
|
Buy
Maintained
| $12 |
202%
upside
| 2 | +12% |
0
%
| 18 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $38 |
128%
upside
| 1 | +15% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $2.50 |
35%
upside
| 1 | – |
–
| 20 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $5 |
23%
upside
| 1 | +9% |
0
%
| 14 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $100 |
43%
upside
| 2 | +15% |
0
%
| 13 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $20 |
374%
upside
| 1 | +3.4% |
0
%
| 13 Nov ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| $7 |
20%
downside
| 1 | +39% |
0
%
| 13 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $72 |
1%
downside
| 2 | +15% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $4 |
142%
upside
| 1 | +2.6% |
0
%
| 4 Nov ‘25 2 months ago |
|